200,000+ products from a single source!

sales@angenechem.com

Home > Imidazoles > 82358-15-4

82358-15-4

82358-15-4 | 1H-Imidazole-2-thiol

CAS No: 82358-15-4 Catalog No: AG004YMP MDL No:MFCD00005188

Product Description

Catalog Number:
AG004YMP
Chemical Name:
1H-Imidazole-2-thiol
CAS Number:
82358-15-4
Molecular Formula:
C3H4N2S
Molecular Weight:
100.1423
MDL Number:
MFCD00005188
IUPAC Name:
1,3-dihydroimidazole-2-thione
InChI:
InChI=1S/C3H4N2S/c6-3-4-1-2-5-3/h1-2H,(H2,4,5,6)
InChI Key:
OXFSTTJBVAAALW-UHFFFAOYSA-N
SMILES:
Sc1ncc[nH]1
EC Number:
212-823-4
UNII:
FD37BLD6L2
NSC Number:
112715

Properties

Complexity:
87  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
100.01g/mol
Formal Charge:
0
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
1  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
100.139g/mol
Monoisotopic Mass:
100.01g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
56.2A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.3  

Literature

Title Journal
Dynamics induced by β-lactam antibiotics in the active site of Bacillus subtilis L,D-transpeptidase. Structure (London, England : 1993) 20120509
99mTc(I) scorpionate complexes for brain imaging: synthesis, characterization and biological evaluation. Current radiopharmaceuticals 20120401
3-Fluoro-12H-benzimidazo[2,1-b][1,3]benzothia-zin-12-one. Acta crystallographica. Section E, Structure reports online 20120201
Thiazole- and imidazole-containing peptidomimetic inhibitors of protein farnesyltransferase. Bioorganic & medicinal chemistry letters 20110915
Reengineering rate-limiting, millisecond enzyme motions by introduction of an unnatural amino acid. Biophysical journal 20110720
Thiol-disulfide redox dependence of heme binding and heme ligand switching in nuclear hormone receptor rev-erb{beta}. The Journal of biological chemistry 20110211
2-({4-[(1H-Imidazol-2-ylsulfanyl)methyl]-2,5-dimethylbenzyl}sulfanyl)-1H-imidazole. Acta crystallographica. Section E, Structure reports online 20101101
Synthesis and biological testing of N-aminoimidazole-based p38alpha MAP kinase inhibitors. ChemMedChem 20100705
Electrochemically derived redox molecular architecture: a novel electrochemical interface for voltammetric sensing. ACS applied materials & interfaces 20100501
A concise synthesis of substituted thiourea derivatives in aqueous medium. The Journal of organic chemistry 20100402
Bis(imidazoline-2-thione)-copper(I) catalyzed regioselective boron addition to internal alkynes. Chemical communications (Cambridge, England) 20100207
Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria. Molecular genetics and metabolism 20090601
Rhenium(I) tricarbonyl complexes with poly(azolyl)borates generated in situ from an organometallic precursor containing the B-H...Re coordination motif. Inorganic chemistry 20090504
Synthesis and characterization of bis[(2-ethyl-5-methyl-imidazo-4-yl)methyl]sulfide and its coordination behavior toward Cu(II) as a possible approach of a copper site type I. Bioinorganic chemistry and applications 20090101
(4S,5S)-2,2-Dimethyl-4,5-bis-(3-methyl-2-thioxo-2,3-dihydro-1H-imidazol-1-yl-meth-yl)-1,3-dioxolane. Acta crystallographica. Section E, Structure reports online 20080101
A Phase I pharmacokinetic and pharmacodynamic study of PX-12, a novel inhibitor of thioredoxin-1, in patients with advanced solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research 20070401
Functional activity of the mouse flavin-containing monooxygenase forms 1, 3, and 5. Journal of biochemical and molecular toxicology 20070101
Investigation of structure and function of a catalytically efficient variant of the human flavin-containing monooxygenase form 3. Drug metabolism and disposition: the biological fate of chemicals 20061201
Elucidation of the absolute configuration of JNJ-27553292, a CCR2 receptor antagonist, by vibrational circular dichroism analysis of two precursors. Chirality 20060801
Preconcentration and determination of mercury(II) at a chemically modified electrode containing 3-(2-thioimidazolyl)propyl silica gel. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20051101
2-Mercaptoimidazoles, a new class of potent CCR2 antagonists. Bioorganic & medicinal chemistry letters 20050201
MMSPE-RP-HPLC method for the simultaneous determination of methimazole and selected metabolites in fish homogenates. Journal of pharmaceutical and biomedical analysis 20041119
The molecular structure of the tris(2-mercapto-1-tolylimidazolyl)hydroborato zinc(2-mercapto-1-tolylimidazole) complex, [[Tm(p-Tol)]Zn(mim(p-Tol))][ClO4]: intermolecular N-H...OClO3versus intramolecular N-H...S hydrogen bonding interactions of the mercaptoimidazole ligand. Dalton transactions (Cambridge, England : 2003) 20041107
Effects of thyroxine and 1-methyl, 2-mercaptoimidazol on phosphoinositides synthesis in rat liver. Lipids in health and disease 20040101
Reactivity of [Re[kappa(3)-H(mu-H)B(tim(Me))(2)](CO)(3)] (tim(Me) = 2-mercapto-1-methylimidazolyl) toward neutral substrates. Inorganic chemistry 20020506
Normal-phase and stability-indicating reversed-phase high-performance liquid chromatographic methods for the determination of the novel antitumor agent: 1-methylpropyl-2-imidazolyldisulfide. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20020305

Related Products

© 2019 Angene International Limited. All rights Reserved.